Casdin Capital, LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 237 filers reported holding MIRATI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,711,480
+2423.4%
498,427
+1993.0%
2.40%
+3104.0%
Q2 2023$860,400
-95.5%
23,814
-95.3%
0.08%
-95.2%
Q1 2023$18,961,800
-27.2%
510,000
-11.3%
1.56%
-22.6%
Q4 2022$26,053,250
+6.6%
575,000
+64.3%
2.02%
+25.7%
Q3 2022$24,444,000
+275.4%
350,000
+260.8%
1.61%
+191.5%
Q2 2022$6,512,000
-22.7%
97,000
-5.4%
0.55%
+45.8%
Q1 2022$8,428,000102,5000.38%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 2,881,702$14,985,0006.99%
Avoro Capital Advisors LLC 2,383,201$12,393,0001.58%
Broadfin Capital, LLC 2,090,801$10,872,0001.32%
Boxer Capital, LLC 1,037,994$5,398,0001.18%
Ghost Tree Capital, LLC 172,184$895,0000.17%
Baker Brothers Advisors 2,269,198$11,800,0000.10%
Hillhouse Capital Management 725,000$3,770,0000.07%
SABBY MANAGEMENT, LLC 249,735$1,299,0000.07%
Rhenman & Partners Asset Management AB 50,000$260,0000.04%
Trexquant Investment LP 42,879$223,0000.03%
View complete list of MIRATI THERAPEUTICS INC shareholders